HIGHLIGHTS
- who: Khalifa Ababacar Mbaye and collaborators from the In the literature, numerous studies have reported the use of anticoagulation in the primary and secondary prevention of Covid-19-related ischemia stroke [16] [17]The optimal dose of anticoagulation remains unknown, however, the significantly high number of macrovascular thrombosis (16%, %) in critically ill Covid, patients despite the use of preventive low molecular weight heparin suggests inadequate dosage [18] [19]. In our study, curative dose anticoagulation was routine in all patients. A meta-analysis coordinated by WHO and the University of Bristol, which included , international studies from , countries with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.